Antibiotic Exposure Concurrently with Anti-PD1 Blockade Therapy Reduces Overall Survival in Patients with Child–Pugh Class A Advanced Hepatocellular Carcinoma

Antibiotic Exposure Concurrently with Anti-PD1 Blockade Therapy Reduces Overall Survival in Patients with Child–Pugh Class A Advanced Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide with a poor prognosis. Treatment with immune checkpoint inhibitors (ICIs) has improved overall survival in patients with HCC. However, not all patients benefit from the treatment. In this study, 59 patients with HCC...

Full description

Bibliographic Details
Main Authors: Kanan Alshammari, Faizah M. Alotaibi, Futoon Alsugheir, Mohammad Aldawoud, Ashwaq Alolayan, Mohammed Ahmad Algarni, Fouad Sabatin, Mohammad F. Mohammad, Abdulaziz Alosaimi, Faisal M. Sanai, Hassan Odah, Ahmed Saleh Alshehri, Omar S. Aldibasi, Samah Alrehaily, Abdullah S. Al Saleh
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Cancers
Subjects:
antibiotic
Nivolumab
immune checkpoint inhibitor (ICI)
anti-PD-1
hepatocellular carcinoma (HCC)
Online Access:https://www.mdpi.com/2072-6694/16/1/133

Internet

https://www.mdpi.com/2072-6694/16/1/133

Similar Items